Despite Its Fan Base, Newly Authorized "Traditional" Novavax COVID-19 Vaccine Is Having Trouble Gaining a Foothold in the US
JAMA
.
2022 Sep 20;328(11):1026-1028.
doi: 10.1001/jama.2022.13661.
Author
Rita Rubin
PMID:
36001324
DOI:
10.1001/jama.2022.13661
No abstract available
MeSH terms
COVID-19 Vaccines* / therapeutic use
COVID-19* / prevention & control
Drug Approval
Humans
Patient Acceptance of Health Care*
United States
Substances
COVID-19 Vaccines
NVX-CoV2373 adjuvated lipid nanoparticle